Skip to main content
SpringerLink
Log in

Effects of aging on the cerebral distribution of technetium-99m hexamethylpropylene amine oxime in healthy humans

  • Original Article
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Some brain functions decline at a linear rate throughout adulthood. Others remain relatively stable until very late in the life cycle. This study characterized the effects of aging on the regional cerebral distribution of hexamethylpropylene amine oxime (HMPAO) in healthy human volunteers. The sample consisted of 26 men and 18 women with a mean age of 41.6±14.9 years (range: 19–73). Their past medical histories, physical examinations, and laboratory screening tests were normal. Single-photon emission tomography (SPET) scans of the brain were performed with a standardized acquisition and processing protocol on a triple-headed camera equipped with fan beam collimators. A 3-D restorative filter and a correction for uniform attenuation were applied before the images were reinterpolated in planes parallel to the line connecting the frontal and occipital poles. Mean counts per pixel were measured in multiple regions of interest (ROIs) within each hemisphere by custom fitting a set of templates to the images. The mean activity in each ROI was compared with the mean activity per pixel in the whole brain. Regression analyses were used to relate the activity ratios to age with both linear and nonlinear models. The relative concentration of radioactivity decreased significantly with age in most, but not all, gray matter structures. It increased in the white matter regions. The nonlinear model of aging fit the data significantly better than a straight line did. Most of the changes with age occurred during young adulthood. No further changes were detectable after the onset of middle age. The median breakpoint age at which the rate of change became negligible was 36.6 years. Aging significantly affects the relative uptake of HMPAO in healthy humans. It decreases in many gray matter regions and increases in most white matter regions. However, the changes do not appear to be linear. Most seem to occur during young adulthood before people reach their late thirties. The distribution then appears to remain relatively stable throughout middle age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rapp PR, Amaral DG. Individual differences in the cognitive and neurobiological consequences of normal aging.Trends Neurosci 1992; 15: 340–345.

    PubMed  Google Scholar 

  2. Lezak MD. Neuropsychological assessment, 2nd edn. New York: Oxford University Press, 1983.

    Google Scholar 

  3. Bak JS, Greene RL. Changes in neuropsychological functioning in an aging population.J Consult Clin Psychol 1980; 48: 395–399.

    PubMed  Google Scholar 

  4. Harley JP, Leuthold CA, Matthews CG, Bergs LE.Wisconsin Neuropsychological Test Battery T-score norms for older Veterans Administration Medical Center patients. Madison, Wis.: CG Matthews, 1980.

    Google Scholar 

  5. Heaton RK, Grant I, Matthews CG. Differences in neuropsychological test performance associated with age, education, and sex. In: Grant I, Adams KM, eds.Neuropsychological assessment of neuropsychiatric disorders. New York: Oxford University Press; 1986: 100–120

    Google Scholar 

  6. Heaton RK, Grant I, Matthews CG.Comprehensive norms for an expanded Halstead-Reitan Battery. Odessa, Fl.: Psychological Assessment Resources, Inc.; 1991: 5–13.

    Google Scholar 

  7. Alavi A, Hirsch LJ. Studies of central nervous system disorders with single photon emission computed tomography and positron emission tomography: evolution over the past 2 decades.Semin Nucl Med 1991; 21: 58–81.

    PubMed  Google Scholar 

  8. Ell PJ, Hocknell JML, Jarritt PH, Cullum I, Lui D, Campos-Costa D, Nowetnik DP, Pickett RD, Canning LR, Neirinckx RD. A 99m Tc-labelled radiotracer for the investigation of cerebral vascular disease.Nucl Med Commun 1985; 6: 437–441.

    PubMed  Google Scholar 

  9. Sharp PF, Smith FW, Gemmel HG, et al. Technitium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies.J Nucl Med 1986; 27: 171–179.

    PubMed  Google Scholar 

  10. Costa DC, Ell PJ, Cullum ID, Jarritt PH. The in vivo distribution of99Tcm-HMPAO in normal man.Nucl Med Commun 1986; 7: 647–658.

    PubMed  Google Scholar 

  11. Podreka I, Suess E, Goldenberg G, Steiner M, Brucke T, Muller C, Lang W, Neirinckx RD, Deecke L. Initial experience with technetium-99m-HMPAO brain SPECT.J Nucl Med 1987; 28: 1657–1666.

    PubMed  Google Scholar 

  12. Anderson AR. 99mTc-d,l-hexamethylene-proyleneamine oxime99mTc-HMPAO basic kinetic studies of a tracer of cerebral blood flow.Cerebrovasc Brain Metab Rev 1989; 1: 288–318.

    PubMed  Google Scholar 

  13. Nickel O, Nagele-Wohrle B, Ulrich P, et al. RCBF quantification with99mTc-HMPAO-SPECT: theory and first results.Eur J Nucl Med 1989; 15: 1–8.

    PubMed  Google Scholar 

  14. Di Rocco LRJ, Silva DA, Kuczynski BL, Narra RK, Ramalingam K, Jurrisson S, Nunn AD, Eckelman WC. The singlepass extraction and capillary permeability-surface area product of several putative cerebral blood flow imaging agents.J Nucl Med 1993; 34: 641–648.

    PubMed  Google Scholar 

  15. Lassen NA, Andersen AR, Friberg L, Paulson OB. The retention of 99mTc-d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis.J Cereb Blood Flow Metab 1988; 8 Suppl 1: S13-S22.

    PubMed  Google Scholar 

  16. Inugami A, Kanno I, Uemura K, Shishido F, Mrakami M, Tmura N, Fujita H, Higano S. Linearization correction of99mTc-d,l-hexamethylene-propylene oxime (HM-PAO) image in terms of regional CBF distribution: comparison to C15O2 inhalation steady-state method measured by positron emission tomography.J Cereb Bloow Flow Metab 1988; 8 Suppl 1: S52-S60.

    Google Scholar 

  17. Yonekura Y, Nishizawa S, Mukai T, Fujita T, Fukuyama H, Ishikawa M, Kikuchi H, Konishi J, Andersen AR, Lassen NA. SPECT with 99mTc-d,l-hexamethylene-propylene oxime (HM-PAO) compared with regional cerebral blood flow measured by PET: effects of linearization.J Cereb Blood Flow Metab 1988; 8 Suppl 1: S52-S60.

    PubMed  Google Scholar 

  18. Tsuchida T, Yonekura Y, Nishizawa S, Sadato N, Tamaki N, Fujita T, Magata Y, Konishi J. Nonlinearity correction of brain perfusion SPECT based on permeability-surface area product model.J Nucl Med 1996; 37: 1237–1241.

    PubMed  Google Scholar 

  19. Gemmell HG, Evans NTS, Besson JAO, et al. Regional cerebral blood flow imaging: a quantitative comparison of technetium-99m-HMPAO SPELT with C15O2 PET.J Nucl Med 1990; 31: 1595–1600.

    PubMed  Google Scholar 

  20. Anderson AR, Friberg HH, Schmidt JF, Hasselbalch SG. Quantitative measurements of cerebral blood flow using SPELT and [99mTc]-d,l-HMPAO compared to xenon-133.J Cereb Blood Flow Metab 1988; 8: S69-S81.

    PubMed  Google Scholar 

  21. Nishizawa S, Yonekura Y, Fujita T, Senda M, Mukai T, Saji H, Shibata T, Yamamoto K, Tamaki N, Fukuyama H, Harada K, Ishikawa M, Torizuka K. Brain perfusion SPECT with technetium-99m HM-PAO: comparative study with I-123 IMP and CBF measured by PET.J Nucl Med 1987; 28: 569.

    Google Scholar 

  22. Buell U, Stirrer H, Braun H, et al. SPECT with99Tcm-HMPAO and99mTc-pertechnetate to assess regional cerebral blood flow (rCBF) and blood volume (rCBV). Preliminary re sults in cerebrovascular disease and interictal epilepsy.Nucl Med Commun 1987; 8: 519–524.

    PubMed  Google Scholar 

  23. Langen K-J, Herzog H, Rota E, Roosen N Wieler H, Kiwit J, Kuwert T, Storch-Becker A, Feinendegen L. Tomographic studies of rCBF with99mTc-HM-PAO SPECT in comparison with PET in patients with primary brain tumors.Neurosurg Rev 1987; 10: 23–24.

    PubMed  Google Scholar 

  24. Pupi A, Castagnoli A, De Cristofaro MT, Bacciottini L, Petti AR. Quantitative comparison between99mTc-HMPAO and99mTc-ECD: measurement of arterial input and brain retention.Eur J Nucl Med 1994; 21: 124–130.

    PubMed  Google Scholar 

  25. Sperling B, Lassen NA. Hyperfixation of HMPAO in subacute ischemic stroke leading to spuriously high estimates of cerebral blood flow by SPECT.Stroke 1993; 24: 193–194.

    PubMed  Google Scholar 

  26. Tsuchida T, Nishizawa S, Yonekura Y, et al. SPECT images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases: comparison with other cerebral perfusion tracers and PET.J Nucl Med 1994; 35: 27–31.

    PubMed  Google Scholar 

  27. Kuwabara Y, Ichiya Y, Sasake M, Akashi Y, Yoshida T, Fukumura T, Masuda K. Cerebellar vascular response to acetazolamide in crossed cerebellar diaschisis: a comparison of99mTc-HMPAO single-photon emission tomography with15O-H2O positron emission tomography.Eur J Nucl Med 1996; 23: 683–689.

    PubMed  Google Scholar 

  28. Koyama M, Kawashima R, Ito H, Ono S, Sato K, Goto R, Kinomura S, Yoshioka S, Sato T, Fukuda H. SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD.J Nucl Med 1997; 587–592.

  29. Heiss WD, Herholz K, Podreka I, Neubauer I, Pietrzyk U. Comparison of [99mTc]HMPAO SPECT with [18F]fluorometh-ane PET in cerebrovascular disease.J Cereb Blood Flow Metab 1990; 10: 687–697.

    PubMed  Google Scholar 

  30. Papazyan J-P, Delavelle J, Burkhard P, Rossier P, Morel C, Maton B, Pizzolato GP, Rüfenacht DA, Slosman DO. Discrepancies between HMPAO and ECD SPECT imaging in brain tumors.J Nucl Med 1997; 38: 592–596.

    PubMed  Google Scholar 

  31. Som P, Oster ZH, Yamamoto K, Meinken GE, Srivastava SC, Yonekura Y, Ebner SA, Atkins HL, Brill AB, Fawwaz RA, Alderson PO, Coffey J, Carlton E, Hubner KF. Some factors affecting the cerebral and extracerebral accumulation ofN-isopropyl-p-iodo-amphetamine (IMP).Int J Nucl Med Biol 1985; 12: 185–196.

    PubMed  Google Scholar 

  32. Yonekur Y, Fujita T, Nishizawa S, Twasaki Y, Mukai T, Konishi J. Temporal changes in accumulation ofN-isopropyl-p-iodoamphetamine in human brain: relation to lung clearance.J Nucl Med 1989; 30: 1977–1981.

    PubMed  Google Scholar 

  33. Waldemar G, Hasselbalch SG, Andersen AR, Delecluse F, Petersen P, Johnsen A, Paulson OB.99mTc-d,l-HMPAO and SPECT of the brain in normal aging.J Cereb Blood Flow Metab 1991; 11: 508–521.

    PubMed  Google Scholar 

  34. Suess E, Malessa S, Ungersbock K, Kitz P, Podreka I, Heimberger K, Hornykiewicz O, Deecke L. Technetium-99m-d,l-hexamethylpropyleneamine oxime (HMPAO) uptake and glutathione content in brain tumors.J Nucl Med 1991; 32: 1675–1681.

    PubMed  Google Scholar 

  35. Jacquier-Sarlin MR, Polla BS, Slosman DO. Oxido-reductive state: the major determinant for cellular retention of99mTc-HMPAO.J Nucl Med 1996; 37: 1413–1416.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University of Pennsylvania, 110 Donner Building, H.U.P., 3400 Spruce Street, 19104, Philadelphia, PA, USA

    P. David Mozley, Abass Alavi, Ruben C. Gurt, Larry R. Muenz, Barry J. Bunow, Mark H. Stecker & Andrew Newberg

  2. The University of Cairo, Egypt

    Ahmed M. Sadek & Barry J. Bunow

  3. Yonsei University, Seoul, South Korea

    Barry J. Bunow & Hee-Joung Kim

  4. The Medical College of Virginia, Richmond, USA

    Barry J. Bunow & Paul Jolles

Authors
  1. P. David Mozley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmed M. Sadek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Abass Alavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ruben C. Gurt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Larry R. Muenz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Barry J. Bunow
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hee-Joung Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mark H. Stecker
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Paul Jolles
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Andrew Newberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mozley, P.D., Sadek, A.M., Alavi, A. et al. Effects of aging on the cerebral distribution of technetium-99m hexamethylpropylene amine oxime in healthy humans. Eur J Nucl Med 24, 754–761 (1997). https://doi.org/10.1007/BF00879663

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00879663

Key words

Search

Navigation